Concepedia

P. Hortig

PH

Statistics

Publications

4

Citations

244

H-Index

4

Active since

2006

Affiliations

Charité - Universitätsmedizin Berlin(Current)

Westpfalz Klinikum

Franklin University

Klinikum St. Marien Amberg

Johannes Gutenberg University Mainz

P. Hortig is an author at Charité - Universitätsmedizin Berlin specializing in oncology, chemotherapy, and pharmacology.

Publications per year

2006–2011

4

Publications

4

A German multicenter, randomized phase III trial comparing irinotecan–carboplatin with etoposide–carboplatin as first-line therapy for extensive-disease small-cell lung cancer

Alexander Schmittel, Martin Sebastian, Ludwig Fischer von Weikersthal et al. · Annals of Oncology · 2011 · 108 citations

, , +12

A randomized phase II trial of irinotecan plus carboplatin versus etoposide plus carboplatin treatment in patients with extended disease small-cell lung cancer

Alexander Schmittel, Ludwig Fischer von Weikersthal, Martin Sebastian et al. · Annals of Oncology · 2006 · 78 citations · Full text

, , +10

Phase II trial of second-line bendamustine chemotherapy in relapsed small cell lung cancer patients

Alexander Schmittel, Maren Knödler, P. Hortig et al. · Lung Cancer · 2006 · 48 citations

, , +10

Irinotecan plus carboplatin versus etoposide plus carboplatin in extensive disease small cell lung cancer: Results of the German randomized phase III trial

Alexander Schmittel, Martin Sebastian, Ludwig Fischer von Weikersthal et al. · Journal of Clinical Oncology · 2009 · 10 citations

, , +10

1–4 of 4